Right ventricular hypertrophy produced in rats exposed to 10% oxygen for 3 weeks resulted in a ninefold increase in atriopeptin immunoreactivity (APir) and a 160-fold increase in atriopeptin messenger RNA (AP mRNA) in the right ventricular myocardium. A small but significant increase in left ventricular APir and AP mRNA was also present, probably representing the interventricular septum. Right atrial APir was decreased by 50%, but left atrial APir was not different from normoxic controls. Purification of ventricular tissue extracts by highperformance liquid chromatography revealed primarily the high molecular weight prohormone. The development of right ventricular hypertrophy and right ventricular APir content followed a similar time course, each evident at 7 days of hypoxia and reaching a plateau at 14 days. Hypoxia followed by normoxia caused right ventricular APir to fall to control levels within 3 days, despite persistent right ventricular hypertrophy. This data demonstrates that hypoxia can reversibly induce extra-atrial expression of atriopeptin synthesis in the cardiac ventricle.
A triopeptin (AP) is a peptide hormone that is synthesized, stored, and released from adult atrial cardiocytes. This hormone possesses potent diuretic, natriuretic, and vasodilatory properties and inhibits aldosterone, renin, and vasopressin release. The acute stimulus for immediate AP release is thought to be atrial stretch. The combined effects of AP function to modulate fluid, electrolyte, and blood pressure homeostasis. 1 -4 Atriopeptin is stored in atrial granules as a 126-amino acid prohormone, AP-126. AP is released into the circulation in response to atrial stretch that can be produced by volume expansion 5 or pharmacological agents such as /-desamino-arg 8 vasopressin. 6 The major circulating form is the 28-amino acid peptide, AP-28. 7 Plasma levels of AP are elevated in both experimental animals and humans with abnormal blood pressure and blood volume homeostasis including systemic hypertension, 8 -9 congestive heart failure, 10 chronic renal failure," pulmonary hypertension, 12 cardiac arrhythmias, 1314 and the syndrome of inappropriate antidiuretic hormone. 13 It has been demonstrated that AP is found in low concentrations in nonatrial tissues including the brain, kidney, eye, and ventricle. 16 -20 However, this may represent binding of circulating AP to receptors rather than synthesis. 2122 Administration of pharmacological doses of dexamethasone can induce the synthesis of AP messenger RNA (AP mRNA) in several nonatrial tissues including lung, pituitary, and ventricle. 23 Recently we reported that dexamethasone or left ventricular hypertrophy produced by aortic banding resulted in a 2.5-fold increase in both atriopeptin immunoreactivity (APir) and AP mRNA in the left ventricle. The combined manipulations were additive and increased left ventricular APir and AP mRNA more than either treatment alone. Neither aortic banding nor dexamethasone had any effect on right ventricular APir or AP mRNA. 24 In addition, substantial APir and AP mRNA are detectable in the fetal and neonatal rat ventricle, principally in the left ventricle. 23 The purpose of this study was to determine if the right ventricle is also capable of AP synthesis during right ventricular hypertrophy, to describe the time course of induction of right ventricular AP synthesis, and to determine if induction of ventricular AP synthesis is a reversible process. Hypoxia is a potent pulmonary vasoconstrictor, and chronic exposure leads to sustained pulmonary hypertension and the development of right ventricular hypertrophy. 26 In this study, chronic hypoxia was used to selectively induce right ventricular hypertrophy.
Materials and Methods

Induction of Right Ventricular Hypertrophy by Hypoxia
Male Sprague-Dawley rats (250-300 g) were placed in solid plastic cages with perforated steel covers completely sealed except for a small area at one end. The cages were flushed continuously, except for a brief daily cleaning period, with a 1:1 mixture of compressed air and nitrogen gas to produce an environment of 10% oxygen at atmospheric pressure. Total gas flow was set at levels adequate to maintain cage temperature at 72°-76° F and prevent carbon dioxide accumulation. Oxygen concentration was confirmed daily with an oxygen analyzer. Animals maintained in normoxia (21% oxygen) served as controls. All animals received water and food ad libitum.
In the first part of the study, the animals were maintained in the hypoxic environment continuously for 21 days. The animals were then anesthetized with chloral hydrate (350 mg/kg i.p.), the hearts were rapidly excised, and the individual cardiac chambers were dissected and weighed. The tissues were then immediately frozen in liquid nitrogen ( -70° C). Hypoxic animals were randomly divided into two groups, one for extraction and assay for APir (n = 8), and the other for quantitation of AP mRNA (« = 6) in each cardiac chamber. Normoxic animals served as controls (n = 4, each group).
In the second part of the study, we examined the time course and reversibility of ventricular AP synthesis during the development and regression of ventricular hypertrophy. Animals were placed in the hypoxic environment for 3, 7, 14, and 21 days and then killed as described above (n = 4, each group). Other animals were exposed to hypoxia for 14 days then returned to normoxic conditions for 3, 7, and 14 days (n = 4, each group). Finally, an additional group (n = 4) was maintained in hypoxia for 21 days, followed by 21 days of normoxia prior to killing. Again, normoxic animals served as controls.
Atriopeptin Immunoreactivity
Atrial and ventricular tissues were pulverized in liquid nitrogen, and AP was extracted by methods previously described. 7 Briefly, samples were boiled in 1.0N acetic acid (1 ml for atria and right ventricles; 2 ml for left ventricles) for 10 minutes, then homogenized (three 10-second bursts of Tecmar Polytron, Cincinnati, Ohio) and centrifuged for 25 minutes at 12,000g. The supernatant was frozen in liquid nitrogen and stored (-70°C) until assay. APir of the extracts was determined by enzyme immunoassay with guinea pig antisera as previously described. 27 Atrial extracts were diluted 1:5,000 and ventricle extracts 1:50 in 100 mM phosphate (enzyme immunoassay) buffer prior to assay. APir was calculated in comparison to a standard curve of authentic AP-24 (AP 103-126). The intra-assay and interassay variation was 3% and 4%, respectively. Protein content was determined by the bicinchoninic acid (BCA) protein assay using bovine serum albumin as a standard.
High-Performance Liquid Chromatographic Purification of Ventricular Atriopeptin
Extracts of right ventricles from 21-day hypoxia animals and normoxic controls were pooled and partially purified on an octadecylsilane (Sep-pak, Waters Instruments, Rochester, Minnesota) column. Pooled extract (2 ml) was applied to the column and washed with 5 ml of deionized water. APir was eluted with 4 ml of 80% methanol with 20 mM triethylamine. The eluate was lyophilized, reconstituted in 500 fi\ deionized water, and applied to a Vydac C18 reversed-phase column at a flow rate of 1.0 ml/min (solvent A, 0.1% trifluoroacetic acid; solvent B, 100% acetonitrile and 0.05% trifluoroacetic acid; Sigma Chemical, St. Louis). The following linear gradients in B were applied: from 15% to 40% in 30 minutes; from 40% to 60% in 40 minutes.
RNA Isolation
Tissue samples were immediately frozen in liquid nitrogen and stored at -80°. RNA was extracted. Each tissue sample was dispersed in guanidine thiocyanate, RNA was centrifuged through a 5.7 M cesium chloride solution, reconstituted in 2.5 M guanidine hydrochloride, and precipitated twice from ethanol. 28 RNA was quantitated by ultraviolet absorbance at 230, 260, and 280 nm. 29 
Preparation of Atriopeptin mRNA Probe
pMON9102, a subclone of the rat AP complementary DNA (cDNA) in pGEM4 (Promega Biotec, Madison, Wisconsin) described previously, 24 was linearized by cleavage with Xhol (New England Biolabs, Beverly, Massachusetts) using the conditions specified by the enzyme supplier. A 235 base pair-labeled cRNA was transcribed from this template using 1 unit//tl of SP6 RNA polymerase in a 40 fi\ reaction mixture containing 40 mM Tris-HCl, pH 7.9; 6 mM MgCl 2 ; 10 mM dithiothreitol; 2 mM spermidine; 0.1 mM CTP; 2.5 mM each ATP, GTP, and UTP; 50 fid a[ formamide; 8 mM 1,4-piperazinediethanesulfonic acid (PIPES), pH 6.7; 80 mM NaCl; and 0.2 mM Na 2 -EDTA and stored at -80°.
Atriopeptin mRNA Quantitation by Solution Hybridization
Total RNA from atrial samples (0.5 fig) and ventricular samples (5 ^g) was added to 25 fig wheat germ transfer RNA carrier and precipitated with 2.5 volumes of ethanol in screwcap microcentrifuge tubes. The RNA was collected by centrifugation, the pellets were dried, and the RNA was then dissolved in 30 ^tl of 80% formamide; 8 mM PIPES, pH 6.7; 80 mM NaCl; and 0.2 mM Na 2 -EDTA containing 2 x 10* counts/min of labeled RNA per tube. The samples were heated at 85° for 10 minutes and then incubated overnight at 45°. Unhybridized RNA was digested with 50 /xg RNase A and 100 units of RNase Tl (both from BoehringerMannheim, Mannheim, FRG) in 350 /xl of 10 mM Tris-HCl, pH 7.5; 5 mM Na 2 -EDTA; and 300 mM NaCl for 30 minutes at 30°.
For quantitation, 100 fi\ of the RNase-treated hybridization mixture was mixed with 100 /xl of 0.5 mg/ml sonicated salmon sperm DNA in 20 mM Na 2 -EDTA and precipitated by addition of 5 ml cold 10% trichloroacetic acid. After 15 minutes on ice, the precipitates were collected by filtration onto Whatman GF/C filters and washed three times with 5 ml of cold 10% trichloroacetic acid and once with cold 95% ethanol. The filters were dried and radioactivity determined by liquid scintillation counting. Counts recovered were proportional to input atrial RNA up to at least 10 /xg of total atrial RNA (data not shown). All determinations fell within the linear range of the assay. Results are presented as counts per minute in hybrid per microgram of total RNA for purposes of comparison of the relative changes between experimental samples and untreated controls. Samples were also analyzed qualitatively by electrophoresis in gels of 6% polyacrylamide in Tris borate EDTA (TBE) 29 and shown to contain the appropriate size product. All quantitation was done using the more reliable precipitation assay.
Results
Effects of Hypoxia on Cardiac Hypertrophy and Cardiac Atriopeptin
Hypoxia produces pulmonary vasoconstriction, increases cardiac output, and stimulates erythropoiesis, all of which contribute to the development of pulmonary hypertension and right ventricular hypertrophy. The effects of 21 days of hypoxia are summarized in Table 1 . Hypoxia produced a 27% increase in heart weight and a 60% increase in the hematocrit. Cardiac hypertrophy was most marked in the right ventricle with a 93% increase in right ventricular mass. There was also evidence of left ventricular hypertrophy with a 14% increase in left ventricular mass. This may represent hypertrophy of the interventricular septum that was included with the left ventricular free wall. There was also a suggestion of right atrial hypertrophy (data not shown), but this was not statistically significant. Three weeks of exposure to 10% oxygen produced a ninefold increase in right ventricular APir and a fourfold increase in left ventricular APir (Table 1) . 
. Time course and reversal of ventricular APir content (A,C) and ventricular hypertrophy (B,D) produced by hypoxia. Results are expressed as mean±SEM. *p<0.05 compared with normoxia. RV, right ventricle; LV, left ventricle.
This was accompanied by a 50% decrease in right atrial APir. There was no significant change in left atrial APir. The time course of development and reversal of ventricular hypertrophy and atriopeptin synthesis is illustrated in Figure 1 . Significant right ventricular hypertrophy was apparent following 7 days of hypoxia and reached a maximum at 14 days. Return to normoxic conditions resulted in a gradual regression of right ventricular hypertrophy, but significant hypertrophy was still apparent after 14 days of normoxia. The development and reversal of hypoxiainduced right ventricular hypertrophy is in general agreement with previous work by others. 30 Induction of right ventricular AP synthesis was apparent at 7 days of exposure to hypoxia with a twofold increase in right ventricular APir. This corresponded to the initial evidence of significant right ventricular hypertrophy. Right ventricular APir content reached a maximum after 14 days of hypoxia with a sevenfold increase compared to normoxic controls. After return to normoxic environment, right ventricular APir fell to control levels within 3 days despite the persistence of significant right ventricular hypertrophy. In the left ventricle, despite minimal evidence of hypertrophy, there was a twofold increase in APir at 14 and 21 days of hypoxia, and a small but significant increase in left ventricular APir at 3 days after return to normoxia. Again, this may represent induction of the interventricular septum.
Molecular Form of Ventricular Atriopeptin
Atriopeptin is synthesized by atrial myocytes and stored in granules as the 126-amino acid prohormone AP-126. Right ventricular extracts from four 21-day hypoxia and normoxia rats were pooled and purified by reversed-phase, high-performance liquid chromatography (HPLC) after partial purification with octadecylsilane (Waters) columns. Hypoxia extracts contained a total of 177 ng APir prior to purification, and 85.9 ng (48%) was recovered in all HPLC fractions. A total of 60 ng APir comigrated with a standard of purified prohormone AP-126 (fraction [34] [35] [36] . A total of 24.1 ng was recovered from fractions 13-20, representing fragments of the prohormone resulting from the extraction process. Purified standards of AP-24 or AP-28 are recovered in column fraction 24 under the conditions employed. Normoxia ventricular extracts contained a total of 23.5 ng APir prior to purification, and 14.3 ng (61%) was recovered in all HPLC fractions. A total of 10.3 ng was recovered from fractions 34-36, representing the prohormone AP-126, and 4.0 ng was recovered from fractions 13-20. The immunoreactivity in this assay was determined against a standard of AP-24, and the guinea pig antisera possesses only 20% cross-reactivity for the prohormone. Correc-tion for total amounts of prohormone present demonstrates that the pooled hypoxia ventricular extracts contained 300 ng and the normoxic extracts contained 51.5 ng of prohormone.
Atrial and Ventricular Atriopeptin mRNA
Relative AP mRNA levels were determined in all four cardiac chambers of rats exposed to hypoxia for 21 days and normoxic controls (Table 1) . Three weeks of hypoxia induced a 160-fold increase in right ventricular AP mRNA and an eightfold increase in left ventricular AP mRNA. Right atrial AP mRNA content of hypoxic animals was not significantly different from controls; however, left atrial AP mRNA was decreased by 33% compared with normoxic rats. Ventricular AP mRNA was identical to atrial AP mRNA as determined by transcriptional start site and by size on Northern blots. 24 
Discussion
There is substantial biochemical and morphological evidence to suggest that hypertrophy induces the myocyte to express fetal characteristics. Cardiac overload in the adult rat results in the redistribution of ventricular myosin to the fetal V 3 isoform, and the degree of redistribution correlates with the degree of ventricular hypertrophy. 31 - 32 Similarly, reexpression of fetal a-skeletal actin has been demonstrated in the adult rat ventricle after aortic banding. 33 Ultrastructural studies have demonstrated similarities between fetal and hypertrophied adult ventricular myocytes. Fetal mammalian ventricular cells contain electron-dense, membranebound granules that resemble atrial granules. 34 After birth, these granules quickly disappear in the ventricle but become more prominent and numerous in the atria. Ventricular hypertrophy is associated with the reappearance of these atrial-like granules in the ventricular myocyte. 35 It has been demonstrated that fetal and neonatal rat ventricles contain substantial APir and AP mRNA that declines rapidly after birth. 25 This suggests that cardiac overload with the subsequent development of ventricular hypertrophy and reexpression of ventricular AP synthesis represents a regression of the ventricular myocyte to an earlier developmental form. Our previous and present work would support this hypothesis and demonstrates that both the right and left ventricle are capable of AP biosynthesis.
Three weeks of hypoxia resulted in a 50% decrease in right atrial APir, but AP mRNA levels were not different than normoxic controls ( Table 1) . The right atrium contains substantially more stored APir and a greater APir/AP mRNA ration than the left atrium, suggesting that AP mRNA need not be induced with such large amounts of stored APir. This is supported by a recent report that atrial APir levels are dictated more by release of AP rather than its biosynthesis during chronic salt loading. 36 The left atrium of hypoxic rats revealed a 33% decrease in AP mRNA without a significant change in left atrial APir. In this study, left atrial APir of hypoxic rats was increased over controls, but this was not statistically significant. This suggests that hypoxic pulmonary hypertension with decreased venous return to the left atrium results in accumulation of synthesized APir and inhibition of AP mRNA synthesis. A recent study using rats exposed to similar degrees of hypoxia for 21 days demonstrated a significant increase in left atrial APir. 12 Another report has shown that atrial AP mRNA levels decreased to 30% of control levels, and atrial APir increased approximately 100% in waterdeprived rats. 36 Chronic hypoxia with pressure overload of the right heart and decreased venous return to the left heart stimulates AP release from the right atrium and inhibits AP synthesis and release from the left atrium.
Chronic hypoxia produced substantial induction of both right ventricular APir and AP mRNA, with a striking accumulation of AP mRNA. The major portion of APir in the right ventricle represents the high molecular weight prohormone, indicating that the ventricle is capable of synthesizing and storing the entire prohormone. The ratio of APir to AP mRNA appears to be substantially lower in the ventricle. This may represent a lower translation rate but more likely represents enhanced protein turnover with rapid synthesis and release of the peptide by the ventricle. A recent report supporting this interpretation demonstrated that neonatal ventricular myocytes in culture release AP through a constitutive pathway, but atrial myocytes store and release AP through a regulated pathway. 37 The fundamental mechanism underlying the development of myocardial hypertrophy and the induction of new genetic expressions (including ventricular AP synthesis) is not well understood. The final common pathway may be mediated through a humoral/trophic factor (e.g., catecholamines) or perhaps by a direct response to increased load (myocyte stretch). 38 Evidence supporting the first hypothesis includes data showing that chronic subhypertensive doses of norepinephrine causes left ventricular hypertrophy 39 ; that increased cardiac sympathetic nerve activity or elevated circulating catecholamines are present in nearly all forms of cardiac hypertrophy 40 -41 ; and that a trophic factor produced by hypertrophied ventricular myocardium increases RNA and protein synthesis when infused into isolated normal hearts. 42 Support for the view that hypertrophy is a direct response to increased load includes evidence that stretch of isolated, denervated cardiac tissue immediately stimulates protein synthesis 43 ; that /3-adrenergic blockade 44 or chemical sympathectomy 43 does not effect right ventricular hypertrophy produced by chronic hypoxia; and that altered cardiac load produces marked, reversible alterations in cardiac structure and function independent of cardiac innervation or catecholamines. 46 - 49 The view that myocyte stretch itself stimulates myocardial hypertrophy is conceptually attractive with regard to the induction of ventricular AP synthesis since atrial stretch is thought to be the stimulus for AP release from the atria. Perhaps cardiac overload with chronic ventricular myocyte stretch stimulates the ventricular cardiocytes to synthesize and secrete AP in an attempt to compensate for the increased load. In this study, the time course of right ventricular hypertrophy was nearly identical to the induction of right ventricular AP synthesis. However, upon return to normoxic conditions and removal of right ventricular pressure overload, there was an abrupt cessation of right ventricular AP synthesis that preceded the complete regression of ventricular hypertrophy. This suggests that the hypoxia-induced expression of ventricular AP may require continued stimulation (e.g., from the right ventricular stretch due to pulmonary hypertension) for its initiation and maintenance.
It has been shown that hypoxia stimulates AP release both in vivo 12 and in vitro. 50 In vivo release may be mediated by pulmonary vasoconstriction and increased right atrial pressure. In vitro release in the nonworking isolated perfused heart suggests that hypoxia may have a direct effect on AP release. Myocyte stretch increases myocardial oxygen consumption, and tissue hypoxia may represent the underlying mechanism of AP release. Similarly, tissue hypoxia may stimulate the induction of AP synthesis in the ventricle. In contrast to most models of left ventricular pressure overload, right ventricular pressure overload results in increased ventricular wall stress, but coronary perfusion pressure is not concomitantly increased. 38 Therefore, in hypoxia-induced pulmonary hypertension, the most severe degree of tissue hypoxia occurs in the right ventricle. Enhanced AP synthesis and release in hypoxia may function to reduce cardiac afterload and myocardial oxygen consumption through its vasodilatory effects. In addition, pulmonary vasodilation will promote gas exchange via a more favorable ventilation-perfusion relation.
